SME Times is powered by   
Search News
Just in:   • NDA show of strength: Nitish Kumar takes oath as Bihar CM for 10th time, PM Modi attends ceremony   • S. Korea to raise anti-dumping tariffs for 2 Chinese PET film companies  • Govt reviews RBI's proposal on opening foreign bank branches, Indian banks’ global expansion  • Sensex, Nifty end near record highs as financials lead rally  • Renewable energy share in India’s power mix likely to cross 35 pc by 2030 
Last updated: 27 Sep, 2014  

ConvaTec Launches Operations In India

PR Newswire | 14 Dec, 2012
ConvaTec Launches Operations In India

BANGALORE, India: ConvaTec, a world-leading developer of innovative medical technologies, is pleased to announce the launch of operations in India.

ConvaTec has opened an office in Bangalore at the World Trade Center, which will serve as headquarters for the company's Indian operations.  The India office will be inaugurated by the CEO of ConvaTec, Mr. Ken Berger, on Friday, December 14. 

The company has also set up a warehouse at Nelamangala on the outskirts of Bangalore, and expects to expand across the country.

"We are excited to begin our operations in India. With a fast-moving economy, India is on the cusp of exciting times, and ConvaTec is committed to growth and a long-term presence in the country," said Ken Berger, CEO of ConvaTec. "We look forward to bringing innovative healthcare technologies and treatments to the Indian market. We view this as an important first step in building a strong presence in an important growth market for ConvaTec."

ConvaTec will market and distribute a variety of innovative medical products to hospitals and other healthcare providers in India. These include advanced wound dressings for patients with acute and chronic wounds such as burns, diabetic foot ulcers, pressure ulcers, and venous leg ulcers; and products for those with an ostomy following surgery for colorectal cancer or inflammatory bowel disease. In addition, the company will provide a wide range of hospital products, including catheters and other products used to manage incontinence and support critical care.

"India is making rapid strides towards world-class healthcare, and ConvaTec is uniquely positioned to address these growing needs," said Anand Shirur, Managing Director for ConvaTec in India. "We are bringing affordable, high-tech solutions to hospitals and wound clinics, enabling easy access and benefits from the latest medical technologies."

As in many countries, hospitals and clinics in India face the challenge of providing advanced treatments for increasing incidences of lifestyle and chronic diseases.  "ConvaTec is committed to meeting the needs of healthcare professionals and patients in India with unique products that promote healing, improve care and guard against infection," added Shirur.

About ConvaTec

ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide.  With four key focus areas – Ostomy Care, Wound Therapeutics, Continence and Critical Care, and Infusion Devices – ConvaTec products support healthcare professionals from the hospital to the community health setting.  The company has world class manufacturing on nearly every continent and a production network of 12 plants in nine countries. For more information, please visit www.convatec.com.

SOURCE ConvaTec

 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹88.70
₹87
UK Pound
₹119.90
₹116
Euro
₹104.25
₹100.65
Japanese Yen ₹59.20 ₹57.30
As on 30 Oct, 2025
  Daily Poll
Who do you think will benefit more from the India - UK FTA in the long run?
 Indian businesses & consumers.
 UK businesses & consumers.
 Both will gain equally.
 The impact will be negligible for both.
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter